200 bed hospital 200

year
land 15000000 bed utalization rate
construction cost 6000000000 revenue per bed
cost of equipment and fixtures 4000000000 increase in revenue per bed
construction period 3 no of bed
total cost of construction 10000000000 total revenue from beds
avr revenue per bed per bed 15000 salaries fixed cost from beds
operating margin 0.1 operating income

cost of capital opd service

equity 0.5 no of patients
debt 0.5 increase in % opd patients
cost of debt revenue from opd
3 month kibor rate 0.0975 assumed consultant cost
spread 0.02 fixed cost with opd
cost of debt 0.1175 operating income
pharmancy
cost of equity 0.18 noof patient
cost of capital 14.875% each patient spend
loan repayment installment per year $875,884,112.49 total revenues from pharmacy
depreciation 200000000 operating income

total oprating income (ebitda)

lease payemnts
less: loan repayment
add depreciation
construction cost
fcff
irr
 0 1 2 3 4
0.2
15000

40
219000000
87,600,000.00
131,400,000.00

100

54750000
N 21900000
10950000
21900000

140
500
25,550,000.00
2,555,000.00

0 0 0 155,855,000.00
15000000 15000000 15000000 15000000
$875,884,112.49 $875,884,112.49 $875,884,112.49 $875,884,112.49

$1,666,666,666.67 $1,666,666,666.67 $1,666,666,666.67

0 ($2,557,550,779.16) ($2,557,550,779.16) ($2,557,550,779.16) (735,029,112.49)
3.81%
 5 6 7 8 9
0.4 0.6 0.8 0.9 0.9
16500 18150 19965 21961.5 24157.65
0.1 0.1 0.1 0.1 0.1
80 120 160 180 180
481800000 794970000 1165956000 1442870550 1587157605
192720000 317988000 466382400 577148220 634863042
289080000 476982000 699573600 865722330 952294563

120 144 172.8 207.36 248.832

0.2 0.2 0.2 0.2 0.2
65700000 78840000 94608000 113529600 136235520
26280000 31536000 37843200 45411840 54494208
13140000 15768000 18921600 22705920 27247104
26280000 31536000 37843200 45411840 54494208

200 264 332.8 387.36 428.832

500 500 500 500 500
36,500,000.00 48,180,000.00 60,736,000.00 70,693,200.00 78,261,840.00
3,650,000.00 4,818,000.00 6,073,600.00 7,069,320.00 7,826,184.00

319,010,000.00 513,336,000.00 743,490,400.00 918,203,490.00 1,014,614,955.00

15000000 15000000 15000000 15000000 15000000
$875,884,112.49 $875,884,112.49 $875,884,112.49 $875,884,112.49 $875,884,112.49

(571,874,112.49) (377,548,112.49) (147,393,712.49) 27,319,377.51 123,730,842.51

 10
0.9
26573.415
0.1
180
1745873365.5
698349346.2
1047524019.3

1,996,700,197.50
298.5984
0.2
163482624
65393049.6
32696524.8
65393049.6

478.5984
500
87,344,208.00
8,734,420.80

1,121,651,489.70 ev- editda 11

15000000 ev at year 10 12,173,166,386.70
$875,884,112.49
1,106,651,489.70
ev- editda 9
12,403,933,763.91 ev at year 10 10,094,863,407.30

4%
 2019 2020
trade recieveable (a) 7,071,272.00 5,701,537.00
sales (b) 57287837 53941017
receive T/O (b/a)=c 8.10 8.45
days receiveable out standing (365/c) 45.05 43.21

cogs a 45,305,673 44,871,541

inventory b 21,369,532 25,829,952
inv t/o a/b 2.1201059995137 1.90135726907523
days sales of inv 365/c 172.161203300081 191.968130312262

payables a 9,637,514 12,111,544

payable T/O (cogs/paybles) 4.7009709142835 4.12629742400797
days payable outstanding 77.6435350601679 88.4570263588674

cash conversion cycle (B6+B11-B15) 139.57 146.73

the cash conversion cycle has increased over the year and the reason behind this could be the increase in days sales of invento
ease in days sales of inventory.